4 completed, 2 terminated. 6 Phase 1, 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 6 | Completed 4, Terminated 2 |
| Phase 2 | 2 | Terminated 2 |
Follow transarterial chemoembolization: new trials by email Literature Review of transarterial chemoembolization trials Research Report on transarterial chemoembolization
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Assessment of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of GKL-006 Injection in Combination With TACE in Unresectable Hepatocellular Carcinoma GKL-006 Injection, transarterial chemoembolization - Hepatocellular Carcinoma (HCC), Unresectable Hepatocellular Carcinoma | Phase 1 | Completed | Beijing Gene Key Life Technology Co., Ltd | 13 | 2024-04-16 | 2026-09-28 |
| Evaluate the Effect of Tirazamine on Primary Liver Cancer. tirapazamine, Transarterial Embolization, TACE - Hepato Cellular Carcinoma (HCC) | Phase 1 / Phase 2 | Terminated | Zhejiang Raygene Pharmaceuticals Co., Ltd | 16 | 2021-05-14 | 2025-02-27 |
| Safety of Transarterial Chemoembolization (TACE) in the Setting of an Elevated Bilirubin Transarterial chemoembolization - Hepatocellular Carcinoma, Bilirubinemia | Phase 1 | Completed | University of Minnesota | 5 | 2018-01-02 | 2022-03-21 |
| Stereotactic Body Radiation Therapy and Transarterial Chemoembolization in Treating Patients With Liver Cancer That Cannot Be Removed by Surgery Laboratory Biomarker Analysis, Stereotactic Body Radiation Therapy, Transarterial Chemoembolization - Child-Pugh Class A, Child-Pugh Class B | Phase 1 | Completed | Ohio State University Comprehensive Cancer Center | 16 | 2015-07-01 | 2021-10-13 |
| Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver Cancer sorafenib tosylate, doxorubicin hydrochloride, cisplatin - Hepatocellular Carcinoma, Liver Cancer | Phase 1 | Completed | Abramson Cancer Center at Penn Medicine | 18 | 2009-09-01 | 2013-02-26 |
| Combination SBRT With TACE for Unresectable Hepatocellular Carcinoma TACE, SBRT - Carcinoma, Hepatocellular, Hepatobiliary Neoplasm | Phase 1 / Phase 2 | Terminated | Stanford University | 11 | 2009-09-01 | 2016-07-27 |
Carcinoma, Hepatocellular (6) · Hyperbilirubinemia (1) · Liver Neoplasms (1)
Abramson Cancer Center at Penn Medicine (1) · Beijing Gene Key Life Technology Co., Ltd (1) · Ohio State University Comprehensive Cancer Center (1) · Stanford University (1) · University of Minnesota (1) · Zhejiang Raygene Pharmaceuticals Co., Ltd (1)
United States (4) · China (2)
Caifang Ni, M.D (1) · Daniel T Chang (1) · Jun Lv, MD (1) · Michael Soulen (1) · Terence Williams, MD, PhD (1)